Azathramycin (Azaerythromycin A) is a methylated derivative of the antibiotic Azithromycin. It is an antibiotic that targets ribosomes, demonstrating antibacterial activity by inhibiting bacterial protein synthesis. It can be used in research related to infectious diseases. The parent compound, Azithromycin, can selectively target and eliminate senescent human fibroblasts, making it a promising candidate for anti-aging research. Azathramycin is intended for research use only.
- Targets bacterial ribosomes
- Demonstrates antibacterial activity
- Inhibits bacterial protein synthesis
- Methylated derivative of Azithromycin
- Suitable for infectious disease research
- Can be used in anti-aging research
- Affects various ion channels (SCN5A, hERG, KCNQ1+KCNE1, L-type Ca++ channels, and Kir2.1)